Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 601–700 of 1,062
Chaperoning Endoplasmic Reticulum–Associated Degradation (ERAD) and Protein Conformational Diseases
Needham, P. G., Guerriero, C. J., & Brodsky, J. L. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033928 · Cited by 158
“For example, HMG-CoA reductase catalyzes the ratelimiting step in cholesterol biosynthesis and is the target of cholesterol- lowering statins (Goldstein and Brown 1990).”
BackgroundMandal, C. C., Ghosh-Choudhury, N., Yoneda, T., Choudhury, G. G., & Ghosh-Choudhury, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193714 · Cited by 138
Indolfi, C., Cioppa, A., Stabile, E., Lorenzo, E. D., Esposito, G., Pisani, A., Leccia, A., Cavuto, L., Stingone, A. M., Chieffo, A., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00526-4 · Cited by 150
“The effect of simvastatin on the synthesis of farnesyl radicals is responsible for the intracellular inhibition of the ras-raf-MAPKK (mitogen-activated protein kinase kinase) protein’s signal transduction pathway activation (12).”
BackgroundJoo, J. H., Liao, G., Collins, J. B., Grissom, S. F., & Jetten, A. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0931 · Cited by 153
“The nonsterol isoprenoid farnesol (FOH) is produced by dephosphorylation of farnesyl pyrophosphate, a catabolite of the cholesterol biosynthetic pathway (7, 8).”
Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes
Simon, A., & van der Meer, J. W. M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00504.2006 · Cited by 142
Feedback Regulation of Cholesterol Uptake by the LXR–IDOL–LDLR Axis
Zhang, L., Reue, K., Fong, L. G., Young, S. G., & Tontonoz, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.250571 · Cited by 137
“factor SREBP-2, the first sterol-regulated transcription factor to be described.(9) SREBP-2 is an endoplasmic reticulum”
BackgroundInduction of geranyl pyrophosphate pyrophosphatase activity by cholesterol‐suppressive isoprenoids
Case, G. L., He, L., Mo, H., & Elson, C. E. (1995) · Lipids · doi:10.1007/bf02536045 · Cited by 137
Reliance of Host Cholesterol Metabolic Pathways for the Life Cycle of Hepatitis C Virus
Ye, J. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030108 · Cited by 155
“Cholesterol can be synthesized from acetyl-CoA via the mevalonate pathway [16], which also generates several isoprenoids, including farnesyl and geranylgeranyl lipids that are covalently attached to the COOH-terminus of certain proteins [17] (Figure 1).”
BackgroundDessì, S., Batetta, B., Pulisci, D., Spano, O., Anchisi, C., Tessitore, L., Costelli, P., Baccino, F. M., Aroasio, E., & Pani, P. (1994) · Cancer · doi:10.1002/1097-0142(19940115)73:2<253::aid-cncr2820730204>3.0.co;2-f · Cited by 139
Hultén, L. M., Lindmark, H., Diczfalusy, U., Björkhem, I., Ottosson, M., Liu, Y., Bondjers, G., & Wiklund, O. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118436 · Cited by 137
“The SRE-1 appears to be involved in the negative, coordinate regulation of these genes in response to cellular sterol levels (51).”
BackgroundWang, X., Pai, J., Wiedenfeld, E. A., Medina, J. C., Slaughter, C. A., Goldstein, J. L., & Brown, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.18044 · Cited by 149
Self-citationOmer, C. A., Kral, A. M., Diehl, R. E., Prendergast, G. C., Powers, S., Allen, C. M., Gibbs, W. W., & Kohl, N. E. (1993) · Biochemistry · doi:10.1021/bi00070a028 · Cited by 166
Kornblau, S. M., Banker, D. E., Stirewalt, D., Shen, D., Lemker, E., Verstovsek, S., Estrov, Z., Faderl, S., Cortes, J., Beran, M., et al. (2007) · Blood · doi:10.1182/blood-2006-08-044446 · Cited by 139
Carlberg, M., Dricu, A., Blegen, H., Wang, M., Hjertman, M., Zickert, P., Höög, A., & Larsson, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17453 · Cited by 135
Lammert, F., Carey, M. C., & Paigen, B. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.20878 · Cited by 143
Kuijk, L. M., Beekman, J. M., Koster, J., Waterham, H. R., Frenkel, J., & Coffer, P. J. (2008) · Blood · doi:10.1182/blood-2008-03-144667 · Cited by 138
PepperHub, an Informatics Hub for the Chili Pepper Research Community
Liu, F., Yu, H., Deng, Y., Zheng, J., Liu, M., Ou, L., Yang, B., Dai, X., Ma, Y., Feng, S., et al. (2017) · Molecular Plant · doi:10.1016/j.molp.2017.03.005 · Cited by 135
Policosanol Modulates HMG-CoA Reductase Activity in Cultured Fibroblasts
Menéndez, R. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(00)00265-4 · Cited by 137
Cenedella, R. J. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)82007-8 · Cited by 136
Liu, T.-F., Tang, J.-J., Li, P.-S., Shen, Y., Li, J.-G., Miao, H.-H., Li, B.-L., & Song, B.-L. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.014 · Cited by 127
Swamy, M. V., Patlolla, J. M. R., Steele, V. E., Kopelovich, L., Reddy, B. S., & Rao, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4619 · Cited by 137
Mulder, A. B., van Lijf, H. J., Bon, M. A. M., van den Bergh, F. A. J. T. M., Touw, D. J., Neef, C., & Vermes, I. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)25429-0 · Cited by 136
Wentzinger, L., Bach, T. J., & Hartmann, M.-A. (2002) · PLANT PHYSIOLOGY · doi:10.1104/pp.004655 · Cited by 137
“It is well established that reductase activity is controlled through multivalent feedback regulation, involving both sterols and non-sterol compounds derived from MVA (Goldstein and Brown, 1990).”
BackgroundInfluentialPhytanic acid: production from phytol, its breakdown and role in human disease
van den Brink, D. M., & Wanders, R. J. A. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5463-y · Cited by 155
Dental Implant Surface Enhancement and Osseointegration
Anil, S., Anand, P. S., Alghamdi, H. S., & Janse, J. A. (2011) · InTech eBooks · doi:10.5772/16475 · Cited by 160
SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy
Cheng, X., Li, J., & Guo, D. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180523104541 · Cited by 134
Molecular targets of a human HNF1α mutation responsible for pancreatic β‐cell dysfunction
Wang, H., Antinozzi, P. A., Hagenfeldt, K. A., Maechler, P., & Wollheim, C. B. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4257 · Cited by 148
Verhulst, A., D’Haese, P. C., & De Broe, M. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000136778.32499.05 · Cited by 135
“This is consistent with the OK cell results as well as with the fact that production of essential molecules for isoprenylation of proteins, including GGPP, can be maintained, at least to a certain extent, despite strong inhibition of HMG-CoA reductase (3).”
ResultRole of Multidrug Resistance P-glycoproteins in Cholesterol Esterification
DeBry, P. W., Nash, E. A., Neklason, D. W., & Metherall, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1026 · Cited by 135
Role of RhoA Inactivation in Reduced Cell Proliferation of Human Airway Smooth Muscle by Simvastatin
Takeda, N., Kondo, M., Ito, S., Ito, Y., Shimokata, K., & Kume, H. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0034oc · Cited by 146
“The antiproliferative activity of statins may be mediated by suppressing the synthesis of isoprenoids, such as farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP) ( 14 ), which are involved in membrane localization and activation of small GTPases Ras and Rho families, respectively (13, 15, 16).”
BackgroundAirway remodeling in asthma: New mechanisms and potential for pharmacological intervention
Girodet, P., Ozier, A., Bara, I., de Lara, J.-M. T., Marthan, R., & Berger, P. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.02.001 · Cited by 148
Lammi, C., Zanoni, C., & Arnoldi, A. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.02.021 · Cited by 135
In Vivo Migration: A Germ Cell Perspective
Kunwar, P. S., Siekhaus, D. E., & Lehmann, R. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.103337 · Cited by 149
Meigs, T. E., Roseman, D. S., & Simoni, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.7916 · Cited by 133
Sterols in spermatogenesis and sperm maturation
Keber, R., Rozman, D., & Horvat, S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r032326 · Cited by 144
Mevalonate Pathway and Human Cancers
Tamanoi, F., Azizian, M., Ashrafi, M., & Bathaie, S. Z. (2016) · Current Molecular Pharmacology · doi:10.2174/1874467209666160112123205 · Cited by 138
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis
Bellanti, F., Villani, R., Facciorusso, A., Vendemiale, G., & Serviddio, G. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.023 · Cited by 148
“The subsequent steps occur in the smooth ER, where HMG-CoA reductase reduces HMG-CoA to (3R)3,5-dihydroxy-3-methylpentanoic acid (mevalonate); this enzyme is the major target of regulation in the entire pathway [86].”
Molecular basis of accessible plasma membrane cholesterol recognition by the GRAM domain of GRAMD1b
Ercan, B., Naito, T., Koh, D. H. Z., Dharmawan, D., & Saheki, Y. (2021) · The EMBO Journal · doi:10.15252/embj.2020106524 · Cited by 132
“…mediated, at least in part, by the regulated transport of cholesterol between the PM and the ER, where the sterol regulatory element binding proteins (SREBPs) regulatory network that controls cholesterol biosynthesis and rates of LDL uptake is located (Goldstein & Brown, 1990; Brown et al , 2018).”
Dietary Antioxidants and Paraoxonases Against LDL Oxidation and Atherosclerosis Development
Aviram, M., Kaplan, M., Rosenblat, M., & Fuhrman, B. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_9 · Cited by 146
“…up by macrophages at an enhanced rate via the macrophage scavenger receptors pathway [scavenger receptors type A (SRA), CD-36], which, unlike the LDL receptor, are not subjected to downregulation by the cellular cholesterol content (Aviram 1993; Goldstein and Brown 1990; Steinberg et al. 1989).”
BackgroundCirculation of Cholesterol between Lysosomes and the Plasma Membrane
Lange, Y., Ye, J., & Steck, T. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18915 · Cited by 132
Flint, O. P., Masters, B. A., Gregg, R. E., & Durham, S. K. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8131 · Cited by 132
Cole, S. L., Grudzien, A., Manhart, I. O., Kelly, B. L., Oakley, H., & Vassar, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413895200 · Cited by 134
Rolfe, B. E., Worth, N. F., WORLD, C., Campbell, J. H., & CAMPBELL, G. R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.023 · Cited by 145
Redman, C. M., & XIA, H. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03535.x · Cited by 132
Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link
Tricarico, P., Crovella, S., & Celsi, F. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160716067 · Cited by 132
“HMGR is the rate-limiting enzyme for the mevalonate pathway and is one of the most finely regulated enzymes [1].”
BackgroundAyukawa, Y., 安川英輔, Moriyama, Y., Ogino, Y., Wada, H., Atsuta, I., & Koyano, K. (2008) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2008.07.013 · Cited by 147
Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures
Singh, V. K., Beattie, L. A., & Seed, T. M. (2013) · Journal of Radiation Research · doi:10.1093/jrr/rrt048 · Cited by 137
“This is a mechanism different from common HMG-CoA reductase inhibitors such as statins that inhibit the rate-limiting step in the sterol biochemical pathway and the conversion of HMG-CoA to mevalonate [47].”
BackgroundWang, H., Nagegowda, D. A., Rawat, R., Bouvier‐Navé, P., Guo, D., Bach, T. J., & Chye, M. (2011) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2011.00631.x · Cited by 146
Is There Potential for Repurposing Statins as Novel Antimicrobials?
Hennessy, E., Adams, C., Reen, F. J., & O'Gara, F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00192-16 · Cited by 133
“In the latter studies, inhibition of bacterial invasion was proposed to be due to the ability of simvastatin and mevastatin to inhibit the activation of Rho GTPase proteins as a result of the inhibition of the production of the isoprenoid intermediates farnesyl-pyrophosphate and geranylgeranyl-pyrophosphate, which are…”
BackgroundPeng, B., Plan, M. R., Chrysanthopoulos, P. K., Hodson, M. P., Nielsen, L. K., & Vickers, C. E. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.12.003 · Cited by 141
Cassera, M. B., Gozzo, F. C., D’Alexandri, F. L., Merino, E. F., Portillo, H. A. D., Peres, V. J., de Almeida, I. C., Eberlin, M. N., Wunderlich, G., Wiesner, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408360200 · Cited by 151
Kuzuyama, T., Takagi, M., Takahashi, S., & Seto, H. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.4.891-897.2000 · Cited by 151
“3-Hydroxy-3-methylglutaryl coenzyme A reductase is the rate-limiting enzyme of the mevalonate pathway in humans (6), and its specific inhibitors, pravastatin and related compounds, are used as cholesterol-lowering agents (28).”
BackgroundChiang, J. Y., & Stroup, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32469-9 · Cited by 133
Gierens, H., Nauck, M., Roth, M., Schinker, R., Schürmann, C., Scharnagl, H., Neuhaus, G., Wieland, H., & März, W. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.7.1777 · Cited by 131
Metabolic engineering of volatile isoprenoids in plants and microbes
Vickers, C. E., Bongers, M., Liu, Q., Delatte, T., & Bouwmeester, H. J. (2014) · Plant Cell & Environment · doi:10.1111/pce.12316 · Cited by 150
Current progress in the study on biosynthesis and regulation of ganoderic acids
Shi, L., Ren, A., Mu, D., & Zhao, M. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2871-1 · Cited by 132
“Previous reports have suggested that the terpenes, which are the downstream of MVA, can be synthesized more quickly and the yield can be significantly improved (Chappell et al. 1995; Goldstein and Brown 1990; Hey et al. 2006; Wang and Keasling 2002).”
BackgroundResultHEUSINGER-RIBEIRO, J., EBERLEIN, M., WAHAB, N. A., & GOPPELT-STRUEBE, M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1291853 · Cited by 130
Protein prenylation: key to ras function and cancer intervention?
Khosravi‐Far, R., Cox, A. D., Kato, K., & Der, C. J. (1992) · PubMed · Cited by 136
Rauthan, M., Ranji, P., Aguilera Pradenas, N., Pitot, C., & Pilon, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218778110 · Cited by 132
“pombe, and mammals is especially important in view of the fact that the latter two types of organisms do have the branch of the mevalonate pathway that leads to sterol synthesis (1, 21, 22), which is lacking in C.”
BackgroundTargeting Isoprenoid Biosynthesis for Drug Discovery: Bench to Bedside
Oldfield, E. (2010) · Accounts of Chemical Research · doi:10.1021/ar100026v · Cited by 129
Statins are potential anticancerous agents (Review)
Altwairgi, A. K. (2015) · Oncology Reports · doi:10.3892/or.2015.3741 · Cited by 137
“Statins are inhibitors of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR), commonly used as cholesterol-lowering agents (3), that have proven their effectiveness in the treatment of cardiovascular diseases.”
BackgroundNguyen, A. D., McDonald, J. G., Bruick, R. K., & DeBose-Boyd, R. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704976200 · Cited by 131
Isoprenoid-Mediated Inhibition of Mevalonate Synthesis: Potential Application to Cancer
Elson, C. E., Peffley, D. M., Hentosh, P., & Mo, H. (1999) · Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-87.x · Cited by 146
Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin
Wong, W. W.-L., Tan, M. M., Xia, Z., Dimitroualakos, J., Minden, M. D., & Penn, L. Z. (2001) · PubMed · doi:10.5167/uzh-58181 · Cited by 129
“The statin family of drugs targets HMG-CoA 6 reductase, the rate-limiting enzyme of the mevalonate pathway (1).”
BackgroundBurkhardt, R., Kenny, E. E., Lowe, J. K., Birkeland, A., Josowitz, R., Noel, M., Salit, J., Maller, J. B., Pe'er, I., Daly, M. J., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.172288 · Cited by 130
Marques, M. R., Freitas, R. A. M. S., Carlos, A. C. C., Siguemoto, É. S., Fontanari, G. G., & Arêas, J. A. G. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.07.049 · Cited by 135
“Changes in the activity of several transporter proteins and membrane enzymes related to the cholesterol biosynthesis affect this homeostasis by balancing enteral absorption and endogenous cholesterol (Goldstein & Brown, 1990).”
BackgroundKiener, P. A., Davis, P. M., Murray, J. L., Youssef, S., Rankin, B. M., & Kowala, M. C. (2001) · International Immunopharmacology · doi:10.1016/s0162-3109(00)00272-1 · Cited by 128
Tatman, D., & Mo, H. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00723-6 · Cited by 128
Grosskopf, I., Baroukh, N., Lee, S.-J., Kamari, Y., Harats, D., Rubin, E. M., Pennacchio, L. A., & Cooper, A. D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000186189.26141.12 · Cited by 128
Molecular Cloning and Expression of Rat Squalene Epoxidase
Sakakibara, J., Watanabe, R., Kanai, Y., & Ono, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.17 · Cited by 129
Karpen, S. J., Sun, A.-Q., Kudish, B., Hagenbuch, B., Meier, P. J., Ananthanarayanan, M., & Suchy, F. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15211 · Cited by 130
Berryman, C. E., Preston, A. G., Karmally, W., Deckelbaum, R. J., & Kris-Etherton, P. M. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00383.x · Cited by 125
Why Do Plants Convert Sitosterol to Stigmasterol?
Aboobucker, S. I., & Suza, W. P. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00354 · Cited by 135
“org 3 March 2019 | Volume 10 | Article 354 (Goldstein and Brown, 1990).”
BackgroundStructure and functions of human oxysterol 7α-hydroxylase cDNAs and gene CYP7B1
Wu, Z., Martin, K. O., Javitt, N. B., & Chiang, J. Y. L. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32094-0 · Cited by 129
The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells
van de Donk, N. W. C. J., Kamphuis, M., Lokhorst, H. M., & Bloem, A. C. (2002) · Leukemia · doi:10.1038/sj.leu.2402501 · Cited by 127
Steele, M. A., Vandervoort, G., AlZahal, O., Hook, S. E., Matthews, J. C., & McBride, B. W. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00117.2010 · Cited by 127
“HMGCR is the ratelimiting enzyme of cholesterol biosynthesis and is considered to be one of the most highly regulated enzymes in nature (24).”
Terpenes: Chemistry, Biological Role, and Therapeutic Applications
Brahmkshatriya, P. P., & Brahmkshatriya, P. S. (2013) · Springer eBooks · doi:10.1007/978-3-642-22144-6_120 · Cited by 164
Linthout, S. V., Riad, A. H., Dhayat, N. A., Spillmann, F., Du, J., Dhayat, S. A., Westermann, D., Hilfiker‐Kleiner, D., Noutsias, M., Laufs, U., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0719-8 · Cited by 134
“Effect of atorvastatin on intramyocardial inflammation Many of the pleiotropic effects of statins are mediated by antagonism of isoprenoid-mediated activation of small GTP-binding proteins, including RAC1 and RHOA [11], which have previously been suggested to be mediators of inflammation [23, 40].”
BackgroundRoglans, N., Sanguino, E., Peris, C., Alegret, M., Vázquez‐Carrera, M., Adzet, T., Díaz, C., Hernández, G., Laguna, J. C., & Sánchez, R. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.232 · Cited by 144
“The effect of HMG-CoA reductase inhibitors on cholesterol homeostasis is complex and may not be confined to the blockage of cholesterol biosynthesis (Goldstein and Brown, 1990).”
Widom, R. L., Ladias, J. A., Kouidou, S., & Karathanasis, S. K. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.677 · Cited by 128
Physiology and pathophysiology of liver lipid metabolism
Ponziani, F. R., Pecere, S., Gasbarrini, A., & Ojetti, V. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1056156 · Cited by 145
“Cholesterol production is also regulated by the sterol regulatory element binding proteins (SREBP), which bind the nuclear sterol response element (SRE) when cells are depleted of sterols, activating the transcription of genes involved in cholesterol synthesis [24,25].”
BackgroundElson, C. E. (1995) · Journal of Nutrition · doi:10.1093/jn/125.suppl_6.1666s · Cited by 125
Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase
Tozawa, R.-I., Ishibashi, S., Osuga, J.-I., Yagyu, H., Oka, T., Chen, Z., Ohashi, K., Perrey, S., Shionoiri, F., Yahagi, N., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30843 · Cited by 125
Activation of the hepatic LDL receptor promoter by thyroid hormone.
Lopez, D., Abisambra Socarrás, J. F., Bedi, M., & Ness, G. C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.05.001 · Cited by 109
van de Donk, N. W. C. J., Kamphuis, M. M. J., van Kessel, B., Lokhorst, H. M., & Bloem, A. C. (2003) · Blood · doi:10.1182/blood-2003-03-0970 · Cited by 126
Simvastatin suppresses breast cancer cell proliferation induced by senescent cells
Liu, S., Uppal, H., Demaria, M., Desprez, P.-Y., Campisi, J., & Kapahi, P. (2015) · Scientific Reports · doi:10.1038/srep17895 · Cited by 124
The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia
Okin, D., & Medzhitov, R. (2016) · Cell · doi:10.1016/j.cell.2016.02.023 · Cited by 121
Plasmodium salvages cholesterol internalized by LDL and synthesized de novo in the liver
Labaïed, M., Jayabalasingham, B., Bano, N., Cha, S., Sandoval, J., Guan, G., & Coppens, I. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01555.x · Cited by 128
“Cholesterol is synthesized in the ER from acetyl-CoA via the mevalonate pathway (Goldstein and Brown, 1990).”
BackgroundKim, C. M., Goldstein, J. L., & Brown, M. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50064-8 · Cited by 125
Self-citationThe Hedgehog Receptor Patched Is Involved in Cholesterol Transport
Bidet, M., Joubert, O., Lacombe, B., Ciantar, M., Nehmé, R., Mollat, P., Brétillon, L., Faure, H., Bittman, R., Ruat, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023834 · Cited by 136
“We incubated fibroblasts NIH 3T3 with ShhN, cholesterol, the Hh pathway agonist purmorphamine, or with ShhN protein plus lovastatin, an inhibitor of cholesterol biosynthesis [36], and we examined the effects on Smo enrichment in the plasma membrane (Fig.”
MethodSimvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial
Montaner, J., Chacón, P. M., Krupiński, J., Rubio, F. J., Millán, M., Molina, C. A., Hereu, P., Quintana, M., & Álvarez‐Sabín, J. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02015.x · Cited by 123
“By inhibiting L-mevalonic acid synthesis, statins also prevent the synthesis of other important isoprenoid intermediates of the cholesterol biosynthetic pathway, such as farnesyl pyrophosphate and geranylgeranyl pyrophosphate [13].”
BackgroundValenza, M., Leoni, V., Tarditi, A., Mariotti, C., Björkhem, I., Di Donato, S., & Cattaneo, E. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.004 · Cited by 115
Automated chemical hypothesis generation and database searching with Catalyst®
Sprague, P. W. (1995) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174464 · Cited by 123
Signals for the induction of nitric oxide synthase in astrocytes
Saha, R. N., & Pahan, K. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.007 · Cited by 136
“Isoprenoids like farnesyl- and geranylgeranylpyrophosphate, are biosynthesized in animals from acetyl CoA via the mevalonate pathway (Goldstein and Brown, 1990), as is depicted in Fig.”
BackgroundCholesterol – a biological compound as a building block in bionanotechnology
Hosta‐Rigau, L., Zhang, Y., Teo, B. M., Postma, A., & Städler, B. (2012) · Nanoscale · doi:10.1039/c2nr32923a · Cited by 131
Fukushima, M., Nakano, M., Morii, Y., Ohashi, T., Fujiwara, Y., & Sonoyama, K. (2000) · Journal of Nutrition · doi:10.1093/jn/130.9.2151 · Cited by 142
Massaro, M., Zampolli, A., Scoditti, E., Carluccio, M. A., Storelli, C., Distante, A., & Caterina, R. D. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp375 · Cited by 135
Seybold, S. J., & Tittiger, C. (2002) · Annual Review of Entomology · doi:10.1146/annurev.ento.48.091801.112645 · Cited by 123
Tropical oils: Nutritional and scientific issues
Elson, C. E., & Alfin‐Slater, R. B. (1992) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399209527562 · Cited by 124
Miller, A. C., Karikó, K., Myers, C. E., Clark, E. P., & Samid, D. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530222 · Cited by 123
“Biosynthesis of the required polyisoprenoid intermediate compounds is part of the mevalonate pathway of cholesterol biosynthesis (Goldstein and Brown, 1990).”
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.